Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Breast Neoplasms 2360Neoplasms 1709Prostatic Neoplasms 1201Lung Neoplasms 926Colorectal Neoplasms 886Carcinoma, Non-Small-Cell Lung 869Leukemia, Myeloid, Acute 593Pancreatic Neoplasms 578Multiple Myeloma 551Carcinoma, Hepatocellular 518Brain Neoplasms 516Neoplasm Metastasis 462Head and Neck Neoplasms 458Melanoma 417Ovarian Neoplasms 414Glioblastoma 403Precursor Cell Lymphoblastic Leukemia-Lymphoma 400Stomach Neoplasms 377Uterine Cervical Neoplasms 365Squamous Cell Carcinoma of Head and Neck 362Rectal Neoplasms 342Recurrence 337Sarcoma 327Hematologic Neoplasms 324Colonic Neoplasms 323Lymphoma 321Triple Negative Breast Neoplasms 291Carcinoma, Renal Cell 284Glioma 283Urinary Bladder Neoplasms 281

Interventions

Hizentra 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Agammaglobulinemia × 1 year × Clear all
NCT06976476 2026-03-11

Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
100 enrolled
Plasma cell

Agammaglobulinemia, Multiple Myeloma, Common Variable Immunodeficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡